Biophytis SA

As of December 31, 2024, Biophytis SA carries a market capitalization of 2.71M, placing it among publicly traded companies globally. Its enterprise value stands at 9.02M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Biophytis SA's next confirmed earnings release is scheduled for March 3, 2027.

As of December 31, 2024, Biophytis SA has 7.32M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Biophytis SA maintains a current ratio of 0.25, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 22, 2026, Biophytis SA's stock has declined approximately 75.54% over the past 52 weeks. The 50-day moving average sits at 0.06, while the 200-day moving average is 0.05.

As of December 31, 2024, Biophytis SA holds 268,000.00 in cash and equivalents against 6.61M in total debt, resulting in a net debt position of 6.40M. Total book value stands at -9.67M, with working capital of -11.68M providing operational flexibility.

Biophytis SA's most recent stock split took place on May 3, 2024 with a 400:1 split ratio.